Treating Flu Symptoms May Create More Cases

Medicines that cut fever and pain help viruses replicate and send infectious people out into the world, at a possible cost of an additional thousand U.S. flu deaths a year

 

Illustration of a Bohr atom model spinning around the words Science Quickly with various science and medicine related icons around the text

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Last time you had the flu, did you take anything to relieve your aches and pains? If so, you may have inadvertently made yourself more contagious. Because pain relievers like ibuprofen and acetaminophen cut your fever—allowing flu viruses to replicate more efficiently, and increasing your chance of infecting others.

Now researchers have modeled the public health consequences of this widespread use of over-the-counter pain drugs on flu transmission in the U.S. They estimate that pain meds could increase the number of annual flu cases by five percent. And since seasonal flu kills more than 41,000 Americans a year, that five percent increase in flu victims translates to a thousand additional deaths. The finding is in the journal Proceedings of the Royal Society B. [David J. D. Earn, Paul W. Andrews and Benjamin M. Bolker, Population-level effects of suppressing fever]

Study author David Earn, of McMaster University in Ontario, suggests we should be more mindful when taking meds: "If you decide to take drugs to make yourself feel better, just recognize that you should still consider staying home or not sending kids to school. Even though they feel better, they might be more likely to transmit to others." And hey—the extra rest will do you good.

—Christopher Intagliata

[The above text is a transcript of this podcast.]
 

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe